Credit: Shutterstock photoHealthcare stocks are narrowly higher, this afternoon with the NYSE Healthcare Sector Index rising about 0.2% and shares of healthcare companies in the S&P 500 adding about 0.1% as a group.
In company news, Natural Alternatives International ( NAII ) is up nearly 4% at $5.19 a share after CEO Mark LeDoux forecasts "meaningful" growth in FY14 top-line sales and operating income for the nutritional supplement company.
LeDoux provided no exact figures. His comments came as NAII late Thursday reported fiscal Q4 net income of $0.09 per share, down from an $0.11 per share gain in the year-ago period. Net sales declined 19.6% year over year to $16.8 million on lower contract manufacturing and beta-alanine raw material sales.
Analyst estimates weren't available for comparison.
In other sector news,
(+) TECH, (+5.3%) RW Baird upgrade to Outperform from Neutral, with $90.00 price target.
(-) RNA, (-67.3%) Said its prospective treatment for Duchenne muscular dystrophy did not meet its primary endpoint of improving muscle function in boys and young men with the genetic mutation during Phase III testing.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
